We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+15.27%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.3B
AUM Growth
+$1.38B
Cap. Flow
-$440M
Cap. Flow %
-2.54%
Top 10 Hldgs %
32.07%
Holding
728
New
61
Increased
216
Reduced
343
Closed
55

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$85M
2
ABT icon
Abbott
ABT
+$53.8M
3
EXC icon
Exelon
EXC
+$46.6M
4
BSX icon
Boston Scientific
BSX
+$42.6M
5
ABBV icon
AbbVie
ABBV
+$32.4M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$80.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.5M
3
CRWD icon
CrowdStrike
CRWD
+$45.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.6M
5
MRK icon
Merck
MRK
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 36.26%
2 Healthcare 22.78%
3 Financials 10.33%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIRM icon
176
Mirum Pharmaceuticals
MIRM
$6.89B
$19M 0.11%
373,005
-9,974
-3% -$444K
FICO icon
177
Fair Isaac
FICO
$28.7B
$18.6M 0.11%
10,166
+3,540
+53% +$6.65M
AMP icon
178
Ameriprise Financial
AMP
$46.8B
$18.5M 0.11%
34,723
-36,281
-51% -$17.9M
GWW icon
179
W.W. Grainger
GWW
$65.3B
$18.5M 0.11%
17,786
+970
+6% +$1.01M
ADBE icon
180
Adobe
ADBE
$89.5B
$18.5M 0.11%
47,726
-23,937
-33% -$9.22M
EXAS
181
DELISTED
Exact Sciences
EXAS
$18.4M 0.11%
345,399
-11,576
-3% -$588K
IAG icon
182
IAMGOLD
IAG
$8.47B
$18.4M 0.11%
+2,497,000
New +$17.5M
VZ icon
183
Verizon
VZ
$194B
$18.3M 0.11%
422,583
+9,174
+2% +$397K
GL icon
184
Globe Life
GL
$13.5B
$18M 0.1%
+144,789
New +$17.6M
STN icon
185
Stantec
STN
$7.69B
$18M 0.1%
165,676
-72,415
-30% -$6.97M
MAR icon
186
Marriott International
MAR
$98.7B
$17.9M 0.1%
65,686
-61,805
-48% -$15.5M
TTEK icon
187
Tetra Tech
TTEK
$8.23B
$17.9M 0.1%
498,259
+41,584
+9% +$1.38M
CCK icon
188
Crown Holdings
CCK
$12.8B
$17.8M 0.1%
172,628
-16,824
-9% -$1.6M
HLT icon
189
Hilton Worldwide
HLT
$74B
$17.7M 0.1%
66,382
-48
-0.1% -$11.4K
DE icon
190
Deere & Co
DE
$170B
$17.2M 0.1%
33,820
+14,349
+74% +$7.02M
ROIV icon
191
Roivant Sciences
ROIV
$25.2B
$17M 0.1%
1,503,994
+1,476,646
+5,399% +$16M
NTRA icon
192
Natera
NTRA
$37.5B
$16.9M 0.1%
99,814
+1,531
+2% +$239K
SUI icon
193
Sun Communities
SUI
$15B
$16.7M 0.1%
131,790
+124,420
+1,688% +$15.4M
MEDP icon
194
Medpace
MEDP
$16.8B
$16.2M 0.09%
51,655
-8,662
-14% -$2.6M
CVS icon
195
CVS Health
CVS
$137B
$15.8M 0.09%
228,388
-5,703
-2% -$374K
T icon
196
AT&T
T
$165B
$15.6M 0.09%
538,376
+7,697
+1% +$212K
HR icon
197
Healthcare Realty
HR
$7.42B
$15.4M 0.09%
969,447
-573,993
-37% -$8.73M
BAP icon
198
Credicorp
BAP
$30.9B
$15.3M 0.09%
68,360
+15,560
+29% +$3.15M
MDGL icon
199
Madrigal Pharmaceuticals
MDGL
$12.6B
$15.1M 0.09%
49,965
+28,593
+134% +$8.52M
FSLR icon
200
First Solar
FSLR
$21.8B
$14.6M 0.08%
88,331
-76,863
-47% -$11.3M

Similar funds

Candriam SCA's Q2 2025 Portfolio in Review

As of Q2 2025, Candriam SCA held 728 positions worth $17.3B, up 8.6% from $16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q2 2025 filing shows 61 new, 216 increased, 343 reduced and 55 closed positions. Its largest new stake was Tapestry: 260,834 shares worth $22.9M. The largest sale was Tesla, an estimated $80.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2025 buy was Tapestry: 260,834 shares worth $22.9M.
  • Candriam SCA added most to Broadcom in Q2 2025, an estimated $85M increase.
  • Candriam SCA's biggest Q2 2025 reduction was Tesla, cutting an estimated $80.5M.
  • Candriam SCA fully exited Banco Macro in Q2 2025, selling an estimated $17.6M.
  • Candriam SCA's ten largest holdings make up 32% of its $17.3B portfolio in Q2 2025.
  • Candriam SCA opened 61 new positions and closed 55 in Q2 2025.
  • Candriam SCA's portfolio value rose 8.6% quarter-over-quarter to $17.3B.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.